132 related articles for article (PubMed ID: 9507661)
1. Quinoxaline chemistry. Part 8. 2-[Anilino]-3-[carboxy]-6(7)-substituted quinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity.
Loriga M; Moro P; Sanna P; Paglietti G; Zanetti S
Farmaco; 1997; 52(8-9):531-7. PubMed ID: 9507661
[TBL] [Abstract][Full Text] [Related]
2. Quinoxaline chemistry. Part 7. 2-[aminobenzoates]- and 2-[aminobenzoylglutamate]-quinoxalines as classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity.
Loriga M; Piras S; Sanna P; Paglietti G
Farmaco; 1997 Mar; 52(3):157-66. PubMed ID: 9212450
[TBL] [Abstract][Full Text] [Related]
3. Quinoxaline chemistry. Part 5. 2-(R)-benzylaminoquinoxalines as nonclassical antifolate agents. Synthesis and evaluation of in vitro anticancer activity.
Loriga M; Fiore M; Sanna P; Paglietti G
Farmaco; 1996; 51(8-9):559-68. PubMed ID: 8930109
[TBL] [Abstract][Full Text] [Related]
4. Quinoxaline chemistry. Part 4. 2(R)-anilinoquinoxalines as nonclassical antifolate agents. Synthesis, structure elucidation and evaluation of in vitro anticancer activity.
Loriga M; Fiore M; Sanna P; Paglietti G
Farmaco; 1995 May; 50(5):289-301. PubMed ID: 7626163
[TBL] [Abstract][Full Text] [Related]
5. Quinoxaline chemistry. Part 16. 4-substituted anilino and 4-substituted phenoxymethyl pyrrolo[1,2-a]quinoxalines and N-[4-(pyrrolo[1,2-a]quinoxalin-4-yl)amino and hydroxymethyl]benzoyl glutamates. Synthesis and evaluation of in vitro biological activity.
Alleca S; Corona P; Loriga M; Paglietti G; Loddo R; Mascia V; Busonera B; La Colla P
Farmaco; 2003 Sep; 58(9):639-50. PubMed ID: 13679156
[TBL] [Abstract][Full Text] [Related]
6. Quinoxaline chemistry. Part 12. 3-Carboxy-2[phenoxy]-6(7)substituted quinoxalines and N-[4-(6(7) substituted-3-carboxyquinoxalin-2-yl)hydroxy] benzoylglutamates. Synthesis and evaluation of in vitro anticancer activity.
Vitale G; Corona P; Loriga M; Paglietti G
Farmaco; 1998; 53(8-9):594-601. PubMed ID: 10081824
[TBL] [Abstract][Full Text] [Related]
7. New alpha-(N)-heterocyclichydrazones: evaluation of anticancer, anti-HIV and antimicrobial activity.
Savini L; Chiasserini L; Travagli V; Pellerano C; Novellino E; Cosentino S; Pisano MB
Eur J Med Chem; 2004 Feb; 39(2):113-22. PubMed ID: 14987820
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives.
Zarranz B; Jaso A; Aldana I; Monge A
Bioorg Med Chem; 2004 Jul; 12(13):3711-21. PubMed ID: 15186857
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel thiazolo[4,5-d]pyrimidine derivatives for antimicrobial, anti-HIV and anticancer investigation.
Rida SM; Habib NS; Badawey EA; Fahmy HT; Ghozlan HA
Pharmazie; 1996 Dec; 51(12):927-31. PubMed ID: 8985982
[TBL] [Abstract][Full Text] [Related]
10. Quinoxaline derivatives. Part II: Synthesis and antimicrobial testing of 1,2,4-triazolo[4,3-a]quinoxalines, 1,2,4-triazino[4,3-a]quinoxalines and 2-pyrazolylquinoxalines.
el-Hawash SA; Habib NS; Fanaki NH
Pharmazie; 1999 Nov; 54(11):808-13. PubMed ID: 10603606
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides.
Carta A; Loriga M; Paglietti G; Mattana A; Fiori PL; Mollicotti P; Sechi L; Zanetti S
Eur J Med Chem; 2004 Feb; 39(2):195-203. PubMed ID: 14987828
[TBL] [Abstract][Full Text] [Related]
12. Quinoxaline chemistry. Part XVII. Methyl [4-(substituted 2-quinoxalinyloxy) phenyl] acetates and ethyl N-([4-(substituted 2-quinoxalinyloxy) phenyl] acetyl) glutamates analogs of methotrexate: synthesis and evaluation of in vitro anticancer activity.
Piras S; Loriga M; Paglietti G
Farmaco; 2004 Mar; 59(3):185-94. PubMed ID: 14987981
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of some novel benzoxazole derivatives as anticancer, anti-HIV-1 and antimicrobial agents.
Rida SM; Ashour FA; El-Hawash SA; ElSemary MM; Badr MH; Shalaby MA
Eur J Med Chem; 2005 Sep; 40(9):949-59. PubMed ID: 16040162
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agents.
Nguyen CH; Fan E; Riou JF; Bissery MC; Vrignaud P; Lavelle F; Bisagni E
Anticancer Drug Des; 1995 Jun; 10(4):277-97. PubMed ID: 7786395
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of (1,4)-naphthoquinono-[3,2-c]-1H-pyrazoles and their (1,4)-naphthohydroquinone derivatives as antifungal, antibacterial, and anticancer agents.
Tandon VK; Yadav DB; Chaturvedi AK; Shukla PK
Bioorg Med Chem Lett; 2005 Jul; 15(13):3288-91. PubMed ID: 15913995
[TBL] [Abstract][Full Text] [Related]
16. Novel functionalized pyrido[2,3-g]quinoxalinones as antibacterial, antifungal and anticancer agents.
Carta A; Sanna P; Gherardini L; Usai D; Zanetti S
Farmaco; 2001 Dec; 56(12):933-8. PubMed ID: 11829113
[TBL] [Abstract][Full Text] [Related]
17. Quinoxaline chemistry. Part 6--Synthesis and evaluation of antiulcer and gastroprotective activity of 2-[arylmethylmercapto-, arylmethylsulfinyl-, piperazinyl-3-R-substituted]quinoxalines.
Piras S; Loriga M; Paglietti G; Demontis MP; Varoni MV; Fattaccio MC; Anania V
Farmaco; 1996; 51(8-9):569-77. PubMed ID: 8930110
[TBL] [Abstract][Full Text] [Related]
18. Derivatives of the new ring system indolo[1,2-c]benzo[1,2,3]triazine with potent antitumor and antimicrobial activity.
Cirrincione G; Almerico AM; Barraja P; Diana P; Lauria A; Passannanti A; Musiu C; Pani A; Murtas P; Minnei C; Marongiu ME; La Colla P
J Med Chem; 1999 Jul; 42(14):2561-8. PubMed ID: 10411476
[TBL] [Abstract][Full Text] [Related]
19. 1,5-Benzodiazepines XIV. Synthesis of new substituted 9H-bis-[1,2,4]triazolo[4,3-a:3',4'-d] [1,5]benzodiazepines and relate compounds endowed with in vitro cytotoxic properties.
Di Braccio M; Grossi G; Ceruti M; Rocco F; Loddo R; Sanna G; Busonera B; Murreddu M; Marongiu ME
Farmaco; 2005 Feb; 60(2):113-25. PubMed ID: 15752470
[TBL] [Abstract][Full Text] [Related]
20. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
